Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 28111-28120 Newer>

The Motley Fool January 17, 2008 Rick Aristotle Munarriz	TiVo at the Movies Jaman.com -- a digital distributor of indie and international films -- announces it will be delivering digital movies through TiVo.
The Motley Fool January 17, 2008 Anders Bylund	Foolish Forecast: Will GE Change the Channel? In advance of earnings, analysts compare GE to some of its peers and competitors.
The Motley Fool January 17, 2008 Nick Kapur	Outperform by $308,000 To beat the market year in and year out -- even by seemingly small margins -- is what turns an otherwise dull, market-meeting portfolio into an explosive vehicle of growth. And it can be done ... quite simply. Read on to see how.
The Motley Fool January 17, 2008 Rick Aristotle Munarriz	Can Your Broker Do This? Discount broker TD AMERITRADE kicks off fiscal 2008 in fine fashion, with first-quarter profits soaring.
The Motley Fool January 17, 2008 Toby Shute	More Profits in the Pipeline The fourth-quarter and annual results are in from Kinder Morgan Energy Partners, and they are excellent.
The Motley Fool January 17, 2008 Bill Mann	A Wish for Bear Stearns: New Coaches at NY & Co. It's time for new management at New York & Company. And since Bear Stearns controls the majority of the stock and much of the board, it won't happen unless Bear says so.
The Motley Fool January 16, 2008 Brian Lawler	Better Safe Than Sorry at Theravance Pharmaceutical company Theravance is raising cash in advance of an FDA hearing. Investors, take note.
The Motley Fool January 16, 2008 Brian Orelli	Forest Labs Not Down -- Yet Double-digit revenue growth is the highlight of a good quarter for Forest Labs, but the company will need a lot more than one solid quarter to get its stock growing again.
The Motley Fool January 16, 2008 Alyce Lomax	All Aboard Volcom? Times are tough in the extreme sports category; Volcom lowers its fourth-quarter 2007 and full-year 2007 guidance, and is revising its full-year 2008 expectations, too.
The Motley Fool January 16, 2008 Brian Lawler	Talking With a Development-Stage Pharma An interview with Dr. Leslie Browne, CEO of development-stage drugmaker Pharmacopeia.
<Older 28111-28120 Newer> Return to current articles.